Tasigna MDL Judge Denies Novartis’ ‘Mystery’ Motion To Remand Cases After 2 Years
ORLANDO, Fla. — The Florida federal judge presiding over the Tasigna atherosclerosis multidistrict litigation has agreed with plaintiffs’ counsel that the timing of defendant Novartis Pharmaceuticals Corp.’s (NPC) motion to remand...To view the full article, register now.
Already a subscriber? Click here to view full article